IP Library Patent Application 17821994
Patent Application
App. No. 17/821,994

DEVICES AND METHODS FOR CONTROLLING DRUG DOSAGE DELIVERY FOR AUTOMATICALLY PROVIDING A DRUG TO A PATIENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/821,994
Abstract

Disclosed are processes and techniques for a drug delivery system to maintain optimal drug delivery for a patient according to a treatment plan. The disclosed techniques enable a drug delivery system to delivery adjusted drug dosages and/or drug delivery cost function aggressiveness factors modified based on clusters or patterns of patient drug dosages and/or response event probabilities. For example, a controller for operating a drug delivery device may operate to determine a plurality of dosage clusters for a patient based on drug dosage patient information, determine an adjustment profile for each of the dosage clusters, determine a current cluster for a dosage cycle, determine an adjusted dosage for the dosage cycle by applying the adjustment profile to a default dosage, and provide a signal to the drug delivery device to deliver the adjusted dosage to the patient for the dosage cycle. Other embodiments are described.

Claims (36)

1 . A controller for operating a drug delivery device, comprising:

a processor; and

a memory storing instructions that, when executed by the processor, operate the controller to:

determine a plurality of dosage clusters for a patient based on drug dosage patient information,

determine an adjustment profile for each of the dosage clusters,

determine a current cluster for a dosage cycle,

determine an adjusted dosage for the dosage cycle by applying the adjustment profile to a default dosage, and

provide a signal to the drug delivery device to deliver the adjusted dosage to the patient for the dosage cycle.

2 . The controller of claim 1 , the drug delivery device comprising an automatic insulin delivery (AID) device.

3 . The controller of claim 1 , the drug comprising one of a hormone, a protein, a chemotherapy drug, a medication, glucagon, a glucagon-like peptide, or insulin.

4 . The controller of claim 1 , the instructions, when executed by the processor, to operate the controller to determine the plurality of clusters based on at least one of a time period or a cluster criterion.

5 . The controller of claim 4 , the time period comprising one of a week, a month, or a year.

6 . The controller of claim 5 , the plurality of clusters segmented based on days of the week.

7 . The controller of claim 4 , the at least one cluster criterion comprising a dosage deviation in drug dosages between portions of a time period.

8 . The controller of claim 7 , the time period comprising a month and the dosage deviation comprising a percentage difference in a dose of the drug between consecutive days of the week.

9 . The controller of claim 8 , the percentage difference comprising about 10% to about 100%.

10 . The controller of claim 1 , the instructions, when executed by the processor, to operate the controller to determine the adjustment profile for each of the dosage clusters based on one or more of:

an overall drug dosage mean and a cluster dosage mean, or

(a cluster dosage mean)/(an overall drug dosage mean).

11 . A method for operating a drug delivery device, comprising, via a processor of a controller:

determining a plurality of dosage clusters for a patient based on drug dosage patient information;

determining an adjustment profile for each of the dosage clusters;

determining a current cluster for a dosage cycle;

determining an adjusted dosage for the dosage cycle by applying the adjustment profile to a default dosage; and

providing a signal to the drug delivery device to deliver the adjusted dosage to the patient for the dosage cycle.

12 . The method of claim 11 , the drug delivery device comprising an automatic insulin delivery (AID) device.

13 . The method of claim 11 , the drug comprising one of a hormone, a protein, a chemotherapy drug, a medication, glucagon, a glucagon-like peptide, or insulin.

14 . The method of claim 11 , comprising determining the plurality of clusters based on at least one of a time period or a cluster criterion.

15 . The method of claim 14 , the time period comprising one of a week, a month, or a year.

16 . The method of claim 15 , the plurality of clusters segmented based on days of the week.

17 . The method of claim 14 , the at least one cluster criterion comprising a dosage deviation in drug dosages between portions of a time period.

18 . The method of claim 17 , the time period comprising a month and the dosage deviation comprising a percentage difference in a dose of the drug between consecutive days of the week.

19 . The method of claim 18 , the percentage difference comprising about 10% to about 100%.

20 . The method of claim 11 , comprising determining the adjustment profile for each of the dosage clusters based on one or more of:

an overall drug dosage mean and a cluster dosage mean, or

(a cluster dosage mean)/(an overall drug dosage mean).

Assignments (2)
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2022
From: LEE, JOON BOK; ZHENG, YIBIN; O'CONNOR, JASON; ANDERSEN, M. THOMAS
To: INSULET CORPORATION
Reel/Frame 060890/0882 →